DDD 3D Systems Corporation

3D Systems Receives FDA Clearance for First-to-Market Multi-material, Monolithic Jetted Denture Solution

3D Systems Receives FDA Clearance for First-to-Market Multi-material, Monolithic Jetted Denture Solution

  • Unique multi-material, single-piece dentures offer unparalleled combination of distinctive break resistance and outstanding aesthetics for enhanced patient experience

  • Solution being implemented by Glidewell, one of the world’s largest dental laboratories
  • FDA clearance represents another important milestone in Company’s strategic initiative to expand its market-leading digital dentistry solution portfolio addressing alignment, protection, repair, replacement of teeth
  • New denture product family significantly expands company’s addressable dental market, with denture demand estimated to exceed $2 billion by 2028

ROCK HILL, S.C., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Today, (NYSE:DDD) announced the Food and Drug Administration (FDA) has provided 510(k) clearance for its . This first-to-market offering comprising two uniquely developed materials — NextDent® Jet Denture Teeth and NextDent® Jet Denture Base — as well as 3D Systems’ jetting technology, software and services, enables the production of durable, long-wear, aesthetically beautiful dentures. As a result of implementing the Company’s FDA-cleared jetted denture solution, dental laboratories can more efficiently deliver dentures, resulting in an enhanced patient experience.

Glidewell, one of the world’s largest producers of restorative dental devices, through its partnership with 3D Systems, received a preview of this solution and is now in the process of implementing it into its production workflow. “We take great pride in pioneering the use of new technologies to continually enhance our products and services,” said Stephenie Goddard, CEO, Glidewell. “We’ve worked with 3D Systems for many years, and using their digital dentistry solutions has helped us achieve tremendous success for our patients. As the first dental lab to have access to 3D Systems’ new multi-material, monolithic jetted denture workflow, we are looking forward to implementing a significantly better denture solution for our customers and their patients.”

“With the FDA clearance of our jetted denture solution, 3D Systems continues to expand our market-leading digital dentistry solution portfolio,” said Neil McCaffrey, vice president & general manager, dental, 3D Systems. “Replacement of teeth is a key pillar of our dental strategy, which is directly supported by this latest innovation. Our jetted denture solution reflects our commitment to the dental laboratory by offering a complete system that enhances automation and profitability within a traditionally labor-intensive workflow. This solution integrates innovations in hardware, software, materials, and process expertise, delivering in a single print session a one-piece denture with hard, wear-resistant, aesthetically beautiful teeth, in combination with tough, durable gingiva properties. Unlike other systems, our printer can produce a denture with true multi-material properties—not just color. With the growing use of digital imaging and personalized treatment planning in dental clinics worldwide, digitizing denture fabrication sets a new standard for creating robust, precise dental prosthetics that patients can truly see and feel. It's a win-win-win for laboratories, dentists, and patients.”

3D printing continues to play a significant role in the production of prosthodontics and its use is accelerating, driven by the benefits it delivers for both manufacturers and patients. According to 360 Market Updates, the global 3D Printed Dentures market size was estimated to be more than $1 billion in 2021 and is forecast to reach more than $2 billion by 20281. 3D Systems’ digital dentistry solutions, including its multi-material, monolithic jetted denture solution, enable dental labs and clinics to streamline dental device production, while reducing material waste and lowering capital investment requirements. Patients also benefit from faster turnaround times for prosthetics, fewer dental appointments, and enhanced device durability and comfort.

For more information on 3D Systems’ jetted denture solution, please visit .

Forward-Looking Statements

Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by terms such as "believes," "belief," "expects," "may," "will," "estimates," "intends," "anticipates" or "plans" or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions, and current expectations and may include comments as to the company’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings "Forward-Looking Statements" and "Risk Factors" in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law.

About 3D Systems

More than 35 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance, and reliability to every interaction — empowering our customers to create products and business models never before possible. Thanks to our unique offering of hardware, software, materials, and services, each application-specific solution is powered by the expertise of our application engineers who collaborate with customers to transform how they deliver their products and services. 3D Systems’ solutions address a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace & defense, automotive, and durable goods. More information on the company is available at .

A photo accompanying this announcement is available at

Investor Contact:
Media Contact:

1 360 Market Updates, “Global 3D Printed Dentures Market Research Report 2022 (Status and Outlook)”, June 2022.



EN
17/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 3D Systems Corporation

 PRESS RELEASE

3D Systems Reports Second Quarter 2025 Financial Results

3D Systems Reports Second Quarter 2025 Financial Results ROCK HILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) --  (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2025. Revenue of $95 million led by double-digit growth in Medical Technology and Aerospace & Defense marketsRegenerative Medicine partnership with United Therapeutics targeted on manufacture of human lungs reached a new printing milestone resulting in a $2 million award in the quarterCost reduction and efficiency programs resulted in over $20 million of savings in operating expenses in Q2Compan...

 PRESS RELEASE

3D Systems Announces Date of Second Quarter 2025 Financial Results

3D Systems Announces Date of Second Quarter 2025 Financial Results ROCK HILL, S.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (NYSE:DDD) announced today it will release its financial results for the second quarter 2025 after the U.S. stock markets close on Monday, August 11, 2025. The company will hold a conference call and simultaneous webcast to discuss these financial results on Tuesday, August 12, 2025 at 8:30 a.m. Eastern Time. Second Quarter 2025 Financial Results Conference Call Date: Tuesday, August 12, 2025 Time: 8:30 a.m. Eastern Time Listen via webcast: Participate via telephon...

 PRESS RELEASE

3D Systems Announces Major Milestone in Digital Dentistry with Full Co...

3D Systems Announces Major Milestone in Digital Dentistry with Full Commercial Release of New FDA-cleared Denture Solution Company’s technology redefines dental prosthetics with revolutionary single-piece, multi-material dentures delivering distinctive combination of exquisite aesthetics, comfort and outstanding resistance to breakage for enhanced patient experienceNextDent® Jetted Denture Solution validated with strong endorsements from beta customers highlighting effortless usability, unmatched material properties and ground-breaking efficiency improvements of up to 300%Commercial availab...

 PRESS RELEASE

3D Systems Advances Regenerative Medical Solutions for First-of-its-Ki...

3D Systems Advances Regenerative Medical Solutions for First-of-its-Kind Peripheral Nerve Repair Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage3D Systems’ bioprinting system enabled production of a 3D-printed bioabsorbable medical device leveraging TISSIUM’s proprietary biomorphic programable polymers—a major industry milestone that sets new standard for high resolution elastomeric 3D-printed medical implantsBuilds on 3D Systems’ pioneering work to develop additive manufacturing ...

 PRESS RELEASE

3D Systems Announces Significant Strengthening of Balance Sheet

3D Systems Announces Significant Strengthening of Balance Sheet Transactions permanently retire approximately $88 million of debt, 41% of prior balance, at a meaningful discount to parRefinancing extends maturity with issuance of $92 million Convertible Senior Secured Notes due 2030Repurchase of 8 million shares, representing approximately 6% of the Company’s outstanding common stock, in connection with the transaction reduces dilution for equity holdersStrong remaining cash reserves support completion of restructuring efforts while maintaining continuity in key growth initiatives ROCK HIL...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch